{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T16:54:33Z","timestamp":1774371273399,"version":"3.50.1"},"reference-count":27,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","heartrhythmjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart Rhythm"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.hrthm.2020.08.014","type":"journal-article","created":{"date-parts":[[2020,8,29]],"date-time":"2020-08-29T00:42:51Z","timestamp":1598661771000},"page":"71-78","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["N-terminal pro\u2013B-type natriuretic peptide is a specific predictor of appropriate device therapies in patients with primary prevention implantable cardioverter-defibrillators"],"prefix":"10.1016","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2490-5106","authenticated-orcid":false,"given":"Jakub","family":"Sroubek","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jason","family":"Matos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Locke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vladimir","family":"Kaplinskiy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yehoshua C.","family":"Levine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Changyu","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfred E.","family":"Buxton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.hrthm.2020.08.014_bib1","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1161\/CIRCULATIONAHA.107.742155","article-title":"Death without prior appropriate implantable cardioverter-defibrillator therapy: a competing risk study","volume":"117","author":"Koller","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2020.08.014_bib2","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1016\/j.hrthm.2015.08.020","article-title":"Contemporary rates of appropriate shock therapy in patients who receive implantable device therapy in a real-world setting: from the Israeli ICD Registry","volume":"12","author":"Sabbag","year":"2015","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2020.08.014_bib3","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1111\/j.1540-8167.2011.02134.x","article-title":"Primary prevention implantable cardioverter defibrillator recipients: the need for defibrillator back-up after an event-free first battery service-life","volume":"22","author":"Van Welsenes","year":"2011","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.hrthm.2020.08.014_bib4","first-page":"e272","article-title":"2017 AHA\/ACC\/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death","volume":"138","author":"Al-Khatib","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2020.08.014_bib5","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1056\/NEJMoa043399","article-title":"Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure","volume":"352","author":"Bardy","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hrthm.2020.08.014_bib6","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1056\/NEJMoa013474","article-title":"Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction","volume":"346","author":"Moss","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hrthm.2020.08.014_bib7","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1056\/NEJMoa1608029","article-title":"Defibrillator implantation in patients with nonischemic systolic heart failure","volume":"375","author":"K\u00f8ber","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hrthm.2020.08.014_bib8","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1056\/NEJM199912163412503","article-title":"A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators","volume":"341","author":"Buxton","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hrthm.2020.08.014_bib9","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1093\/eurheartj\/ehu176","article-title":"Risk stratification for sudden cardiac death: current status and challenges for the future","volume":"35","author":"Wellens","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrthm.2020.08.014_bib10","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1016\/j.bbadis.2013.04.002","article-title":"Electrophysiological changes in heart failure and their implications for arrhythmogenesis","volume":"1832","author":"Coronel","year":"2013","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.hrthm.2020.08.014_bib11","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.hrthm.2014.04.024","article-title":"B-type natriuretic peptide is a major predictor of ventricular tachyarrhythmias","volume":"11","author":"Levine","year":"2014","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2020.08.014_bib12","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.jcmg.2013.12.014","article-title":"LGE and NT-proBNP identify low risk of death or arrhythmic events in patients with primary prevention ICDs","volume":"7","author":"Mordi","year":"2014","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.hrthm.2020.08.014_bib13","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.1161\/01.CIR.0000016642.15031.34","article-title":"B-type natriuretic peptide predicts sudden death in patients with chronic heart failure","volume":"105","author":"Berger","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2020.08.014_bib14","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1002\/clc.20336","article-title":"B-type natruiretic peptide levels stratify the risk for arrhythmia among implantable cardioverter defibrillator patients","volume":"31","author":"Galante","year":"2008","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.hrthm.2020.08.014_bib15","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1136\/hrt.2004.058198","article-title":"Preimplantation B-type natriuretic peptide concentration is an independent predictor of future appropriate implantable defibrillator therapies","volume":"92","author":"Verma","year":"2006","journal-title":"Heart"},{"key":"10.1016\/j.hrthm.2020.08.014_bib16","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.amjcard.2007.03.074","article-title":"Comparison of N-terminal pro-brain natriuretic peptide versus electrophysiologic study for predicting future outcomes in patients with an implantable cardioverter defibrillator after myocardial infarction","volume":"100","author":"Yu","year":"2007","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hrthm.2020.08.014_bib17","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.jacc.2003.09.048","article-title":"Natriuretic peptides as predictors of non-sudden and sudden cardiac death after acute myocardial infarction in the beta-blocking era","volume":"43","author":"Tapanainen","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2020.08.014_bib18","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.jchf.2013.12.004","article-title":"Biomarkers of myocardial stress and fibrosis as predictors of mode of death in patients with chronic heart failure","volume":"2","author":"Ahmad","year":"2014","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.hrthm.2020.08.014_bib19","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1001\/jamacardio.2018.3811","article-title":"Association of multiple biomarkers with risk of all-cause and cause-specific mortality after acute coronary syndromes: a secondary analysis of the PLATO biomarker study","volume":"3","author":"Lindholm","year":"2018","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.hrthm.2020.08.014_bib20","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1161\/01.HYP.0000170140.36633.8f","article-title":"Effect of compensated renal dysfunction on approved heart failure markers: direct comparison of brain natriuretic peptide (BNP) and N-terminal pro-BNP","volume":"46","author":"Luchner","year":"2005","journal-title":"Hypertension"},{"key":"10.1016\/j.hrthm.2020.08.014_bib21","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1161\/01.CIR.0000144310.04433.BE","article-title":"N-terminal-pro-brain natriuretic peptide predicts outcome after hospital discharge in heart failure patients","volume":"110","author":"Bettencourt","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2020.08.014_bib22","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/j.amjcard.2004.12.032","article-title":"The N-terminal Pro-BNP investigation of dyspnea in the emergency department (PRIDE) study","volume":"95","author":"Januzzi","year":"2005","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hrthm.2020.08.014_bib23","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.hrthm.2015.09.022","article-title":"Left ventricular sphericity independently predicts appropriate implantable cardioverter-defibrillator therapy","volume":"13","author":"Levine","year":"2016","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2020.08.014_bib24","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jacc.2013.07.096","article-title":"Regional myocardial sympathetic denervation predicts the risk of sudden cardiac arrest in ischemic cardiomyopathy","volume":"63","author":"Fallavollita","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2020.08.014_bib25","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1161\/01.CIR.81.3.1094","article-title":"Stretch-induced arrhythmias in the isolated canine ventricle. Evidence for the importance of mechanoelectrical feedback","volume":"81","author":"Hansen","year":"1990","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2020.08.014_bib26","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.yjmcc.2009.03.020","article-title":"Sensing pressure in the cardiovascular system: Gq-coupled mechanoreceptors and TRP channels","volume":"48","author":"Sharif-Naeini","year":"2010","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.hrthm.2020.08.014_bib27","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.hrthm.2017.11.012","article-title":"Effects of angiotensin-neprilysin inhibition compared to angiotensin inhibition on ventricular arrhythmias in reduced ejection fraction patients under continuous remote monitoring of implantable defibrillator devices","volume":"15","author":"de Diego","year":"2018","journal-title":"Heart Rhythm"}],"container-title":["Heart Rhythm"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S154752712030850X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S154752712030850X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T06:52:49Z","timestamp":1761547969000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S154752712030850X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["S154752712030850X"],"URL":"https:\/\/doi.org\/10.1016\/j.hrthm.2020.08.014","relation":{},"ISSN":["1547-5271"],"issn-type":[{"value":"1547-5271","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"N-terminal pro\u2013B-type natriuretic peptide is a specific predictor of appropriate device therapies in patients with primary prevention implantable cardioverter-defibrillators","name":"articletitle","label":"Article Title"},{"value":"Heart Rhythm","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hrthm.2020.08.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Heart Rhythm Society. All rights reserved.","name":"copyright","label":"Copyright"}]}}